0

N-Butyldeoxynojirimycin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP72599270
CAS72599-27-0
Structure
MDL NumberMFCD00272581
Molecular Weight219.28
InChI KeyUQRORFVVSGFNRO-UTINFBMNSA-N
Descriptionfilm (dried in situ)
Formfilm (dried in situ)
Size1MG, 5MG
1

N -Butyldeoxynojirimycin Reduces Growth and Ganglioside Content of Experimental Mouse Brain Tumours

M K Ranes, M El-Abbadi, M G Manfredi, P Mukherjee, F M Platt, T N Seyfried

Br J Cancer. 2001 Apr 20;84(8):1107-14.

PMID: 11308262

1

N-butyldeoxynojirimycin Delays Motor Deficits, Cerebellar Microgliosis, and Purkinje Cell Loss in a Mouse Model of Mucolipidosis Type IV

Lauren C Boudewyn, Jakub Sikora, Ladislav Kuchar, Jana Ledvinova, Yulia Grishchuk, Shirley L Wang, Kostantin Dobrenis, Steven U Walkley

Neurobiol Dis. 2017 Sep;105:257-270.

PMID: 28610891

1

N-Butyldeoxynojirimycin Is a Broadly Effective anti-HIV Therapy Significantly Enhanced by Targeted Liposome Delivery

Stephanie Pollock, Raymond A Dwek, Dennis R Burton, Nicole Zitzmann

AIDS. 2008 Oct 1;22(15):1961-9.

PMID: 18753929

1

N-butyldeoxynojirimycin Is a Novel Inhibitor of Glycolipid Biosynthesis

F M Platt, G R Neises, R A Dwek, T D Butters

J Biol Chem. 1994 Mar 18;269(11):8362-5.

PMID: 8132559

1

N-butyldeoxynojirimycin Treatment Restores the Innate Fear Response and Improves Learning in Mucopolysaccharidosis IIIA Mice

Xenia Kaidonis, Sharon Byers, Enzo Ranieri, Peter Sharp, Janice Fletcher, Ainslie Derrick-Roberts

Mol Genet Metab. 2016 Jun;118(2):100-10.

PMID: 27106513

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode